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Background: High invasion and metastasis are the primary factors causing poor prognosis of patients with
hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying these biological behaviors have
not been completely elucidated. In this study, we investigate the molecular mechanism by which hypoxia
promotes HCC invasion and metastasis through inducing epithelial-mesenchymal transition (EMT).
Methods: The expression of EMT markers was analyzed by immunohistochemistry. Effect of hypoxia on induction
of EMT and ability of cell migration and invasion were performed. Luciferase reporter system was used for
evaluation of Snail regulation by hypoxia-inducible factor -1α (HIF-1α).
Results: We found that overexpression of HIF-1α was observed in HCC liver tissues and was related to poor prognosis of
HCC patients. HIF-1α expression profile was correlated with the expression levels of SNAI1, E-cadherin, N-cadherin and
Vimentin. Hypoxia was able to induce EMT and enhance ability of invasion and migration in HCC cells. The same
phenomena were also observed in CoCl2-treated cells. The shRNA-mediated HIF-1α suppression abrogated CoCl2-induced
EMT and reduced ability of migration and invasion in HCC cells. Luciferase assay showed that HIF-1α transcriptional
regulated the expression of SNAI1 based on two hypoxia response elements (HREs) in SNAI1 promoter.
Conclusions: We demonstrated that hypoxia-stabilized HIF1α promoted EMT through increasing SNAI1 transcription in
HCC cells. This data provided a potential therapeutic target for HCC treatment.
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Metastasis is the main cause of deaths for patients with
many solid cancers. Approximately 90% of deaths caused
by cancers result from the metastatic spread of primary
tumors [1]. Therefore, it is critical to understand the
mechanisms of metastasis and to identify new targets for
therapy. Recently, two mechanisms of metastasis have
received significant attention: (1) epithelial mesenchymal
transition (EMT) and mesenchymal epithelial transition
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reproduction in any medium, provided the orand microenvironment [9-15]. EMT is believed to be a
major mechanism by which cancer cells become migra-
tory and invasive. A variety of cancer cells display features
of EMT. In addition, multiple steps of metastasis are
influenced by the tumor microenvironment which may
determine the course and severity of metastasis [16-23] .
Hypoxia is a critical microenvironment in tumor patho-
genesis. It occurs in series of distinct steps that include
tumor cell invasion, intravasation, extravasation and pro-
liferation. There is a close relationship between hypoxia
and tumor metastasis and poor prognosis. Several mecha-
nisms have been proposed to explain how hypoxia might
lead to a poor prognosis in the clinical settings, and none
of which are mutually exclusive [4,24-27].
This hypoxic response is mainly regulated by the
hypoxia-inducible factor 1 (HIF-1), a basic HLHLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and HIF-1β. The HIF-1α subunit is regulated by oxy-
gen tension, whereas HIF-1β is constitutively
expressed [28-32]. Over-expression of HIF-1α is a
common feature of malignant cells and links to poor
prognosis in both lymph-node positive [33] and
lymph-node negative [34] breast carcinoma. Therefore,
the exploration of target genes by HIF-1 may lead to a
better understanding of the contribution of hypoxia to
tumor progression.
HIF-1α activation correlates with metastasis in many
kinds of tumors and promotes metastasis through the
regulation of key factors governing tumor cell meta-
static potential. E-cadherin is a key molecule related to
metastatic potential in the majority of epithelial cancers.
It is a cellular adhesion molecule that regulates cell–cell
adhesion and stimulates anti-growth signals through inter-
actions with β-catenin in cytoplasm [35]. It has been pro-
posed that HIF-1α mediates repression of E-cadherin
expression through the upregulation of E-cadherin-specific
repressors Snail and SIP1 [36]. Similarly, hypoxia promotes
EMT and metastatic phenotypes in human cancer cells via
direct induction of the E-cadherin repressor twist [2].
Hepatocellular carcinoma (HCC) is one of the most
common cancers worldwide. Invasion and metastasis in
early-stage HCC is an important feature and a crucial un-
favorable prognostic factor. Therefore, in this work we in-
vestigated how hypoxia could induce EMT and promote
metastasis of HCC cells.
Methods
Immunohistochemistry
Human liver tissues were obtained from surgical resec-
tion specimens of HCC patients in the Institute of
Hepatobiliary Surgery, Southwest Hospital, Third Military
Medical University. The procedure of human sample col-
lection was approved by the Ethical Committee of Third
Military Medical University. A tissue microarray block
containing 66 HCC tissues was constructed by using a tis-
sue microarrayer. Immunostaining was performed on tis-
sue microarray slides following the routine protocol. The
following antibodies were used: mouse anti-human HIF-
1α monoclonal antibody (BD Clontech, USA), mouse
anti-human E-cadherin monoclonal antibody, mouse anti-
human N-cadherin monoclonal antibody, mouse anti-
human Vimentin monoclonal antibody, rabbit anti-human
Twist polyclonal antibody and rabbit anti-human SNAI1
polyclonal antibody (Santa Cruz Biotech, USA). Assess-
ment of the staining was based on the percentage of posi-
tively stained cells and the staining intensity.
Cell culture
Human HCC cell lines HepG2 and SMMC-7721 were pur-
chased from Shanghai Cell Collection (Shanghai, China).Human embryonic kidney cell line HEK293 was obtained
from Microbix Biosystems (Toronto, ON, Canada). The
cells were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum
(FBS; GIBCO-BRL) at 37°C under a 5% CO2 condition.
CoCl2 was purchased from Sigma-Aldrich (St. Louis, USA).Fluorescent immunostaining
Cells were cultured in 24-well plates at 5 × 104 cells per
well. At the indicated time points, media were removed
from the cultured cells followed by three washings with
PBS. Cells were fixed with 4% polyoxymethylene solu-
tion for 20 min and washed with PBS three times. Cells
were incubated with primary antibodies and then their
corresponding lumophore-conjugated secondary anti-
bodies. DAPI was used for nuclei staining. Finally, cells
were observed under a fluorescent microscope or a con-
focal microscope.Adenoviral vector-mediated HIF-1α silencing
The shRNA specifically targeting HIF-1α mRNA was
generated by annealing the following primers: Forward:
5'-aGTCGGACAGCCTCACCAAAtttt-3'; Reverse: 5'-aT
TTGGTGAGGCTGTCCGACtttt-3', followed by its in-
sertion into pSES-HUS that was digested by SfiI to gen-
erate HIF-1α siRNA pSES-HUS. After digestion of PacI,
HIF-1α siRNA pSES-HUS was transfected into E. Coli
BJ5183 with pAdEasy-1 to obtain recombination plasmid
pAdeasy-HIF-1α siRNA. After identification, pAdeasy-
HIF-1α siRNA was transfected into HEK293 cells for the
production of recombinant adenovirus Ad-HIF-1α siRNA
(Ad-shHIF-1α). The control adenovirus containing a non-
function shRNA (Ad-scrambled) (Forward: 5'-aGACTTC
ATAAGGCGCATGCtttt-3' Reverse: 5'-aGCATGCGCCT
TATGAAGTCtttt-3') is constructed in a similar protocol.
The adenoviruses were harvested and purified with the
CsCl gradient centrifugation method. The titers of adeno-
viruses were quantified through TCID50 assay on HEK293
cells.Quantitative real-time PCR (qRT-PCR)
The SMMC-7721 cells were harvested at the indicated
time points. Total RNA was extracted by using Trizol
(Invitrogen) according to the manufacturer’s protocol.
Reverse transcription was performed according to the
protocol of RevertAidTM First Strand cDNA Synthesis
Kits (Fermentas). Quantitative PCR was performed by
using SYBR premix Ex Taq (TaKaRa) and Applied
Biosystems 7300 Real-Time PCR System (Applied
Biosystems, USA) supplied with analytical software.
The primers used for this study were listed in Additional
file 1: Table S6.
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Total proteins were separated on 8–12% polyacrylamide
gels and transferred onto 0.45 μm nitrocellulose in a buf-
fer containing 25 mmol/L Tris–HCl (pH 8.3), 192 mmol/L
glycine, 20% methanol and blocked with 5% fat-free dry
milk in PBS for 2 h. The membranes were incubated with
primary antibodies, as described in Immunohistochemis-
try. β-actin was used as internal control.
Cell migration and invasion assays
The invasion assays were performed using Millicell inserts
(Millipore, Billerica, MA, USA) coated with Matrigel (BD
Biosciences, Sparks, MD, USA). 2.5 × 104 cells were
seeded per upper chambers in serum-free DMEM whereas
the lower chambers were loaded with DMEM containing
5% FBS. After 24 hrs, the non-migrating cells on the upper
chambers were removed by a cotton swab, and cells in-
vaded through the matrigel layer to the underside of the
membrane were stained by crystal violet. The cell num-
bers were counted. Cell migration assays were performed
similarly, but without Matrigel.
Cell cycle analysis
For identifying cells at different stages of cell cycle, vec-
tor infected cells were prepared as a single cell suspen-
sion of 1–2 × 106 cells/mL in PBS. After the cells were
fixed with pre-cold 70% ethanol for 2 hrs, the cells were
washed two times with PBS and were stained with
Propidium Iodide (PI) at the final concentration of
50 μg/mL with RNase at 20 μg/mL in PBS. Treated cells
were then evaluated by FACS analysis.
Colony formation assay
Colony formation assay was performed by using mono-
layer culture. Cells were plated in a 6-well plate and then
cultured under hypoxic condition. Colonies (>50 cells/
colony) were counted after staining with crystal violet
solution. All the experiments were performed in tripli-
cate wells three times.
Luciferase reporter vector construction
We used genomic DNA of human normal liver as tem-
plate to amplify the promoter of SNAI1 gene. The se-
quences of primer sets were provided upon requested.
The PCR products were digested by KpnI and XhoI,
followed by being inserted into pGL3-basic. The resulting
plasmids harboring various lengths of SNAI1 promoter
were transfected into CoCl2-treated SMMC-7721 cells.
The activity of luciferase was examined at the indicated
time points.
Statistical analysis
Each experiment was performed at least two times. All
values were presented as means ± SD. The statistics wasanalyzed by unpaired, two-tailed t-test. Data were con-
sidered to be statistically significant when p < 0.05 (*)
and p < 0.01 (**).Results
Expression of hypoxia and EMT related genes in human
HCC
In order to know whether hypoxia status is related to
EMT in HCC, we firstly investigated expression levels of
HIF-1α, HIF-2α, SNAI1, Twist, E-cadherin, N-cadherin
and Vimentin in a tissue array containing 66 HCC samples
from human patients by immunohistochemistry. HIF-1α
and SNAI1 expression was detected in 65% (43/66) and
59% (39/66) of tumor samples, respectively. Coexistence
of HIF-1α and SNAI1 was observed in 50% of the cases
(33/66) and their expression level was significantly posi-
tively correlated (P < 0.01) (Additional file 1: Table S1). In
addition, we observed the significant correlations between
HIF-2α and SNAI1 and Twist (Additional file 1: Table S1).
We also compared the expression profiles between EMT
markers and HIF-1α as well as SNAI1. In the HIF-1α posi-
tive samples of HCC patients (n = 43), expression of
E-cadherin and N-cadherin was found in 10 and 34 samples,
respectively. There was a significant negatively correl-
ation in expression level between HIF-1α and E-cadherin
(P < 0.01) and positive correlation between HIF-1α and
N-cadherin (P < 0.01) (Additional file 1: Table S2).
Analysis on SNAI1 expression also showed its correl-
ation with EMT markers in these HCC samples (P < 0.01)
(Additional file 1: Table S2). Our data also showed that
expression of E-cadherin was significant negative correlated
to the expression of N-cadherin and Vimentin (P < 0.01)
(Additional file 1: Table S3).Overexpression of HIF-1α and SNAI1 in HCC predicts poor
prognosis
Overexpression of HIF-1α and SNAI1 in HCC samples
were shown to be correlated with pathological classifica-
tion, TNM staging and tumor volume (P < 0.05). In
addition, HIF-1α expression profile was also correlated with
severity of cirrhosis (P < 0.05) (Additional file 1: Table S4).
Consistent to previous studies, EMT phenotype in HCC
samples was found to be significantly correlated with
pathological classification, TNM staging, numbers of tumor
nodule and tumor size (Additional file 1: Table S5). Progno-
sis of the HCC patients with HIF-1α expression level was
also investigated in our work. Our data showed that
disease-free survival was shorter in HIF-1α positive group
(n = 43, 824 days) compared with HIF-1α negative group
(n = 23, 1144 days, P = 0.0496) (Figure 1). This data suggest
that HIF-1α is correlated with SNAI1 expression and EMT
phenotype of HCC samples and can predict poor prognosis
of HCC patients after surgery.
Figure 1 Overexpression of HIF-1α in HCC is correlated with the level of SNAI1 and EMT markers and predicts poor prognosis.
Immunohistochemistry was performed for determining the expression profile of various proteins, including HIF-1α (A, F), SNAI1 (B, G), E-cadherin
(C, H), N-cadherin (D, I) and Vimentin (E, J), on HIF-1α+ (A-E) and HIF-1α- (F-J) HCC samples (A, D, F, I: ×200; B, C, E, G, H, J: ×400). (K) Disease-free
survival after surgery was compared between HIF-1α positive (n = 43) and HIF-1α negative (n = 23) HCC patients.
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occurred under reoxygenation
The correlation between overexpression of HIF-1α and
EMT induction in HCC tissues suggested that hypoxia
may regulate the EMT of HCC cells. Therefore, we in-
vestigated induction of EMT by hypoxia. We observed
morphological changes with characteristic of obtaining
mesenchymal phenotype and losing epithelial feature in
HCC cell lines under 1% O2 condition. When cells wereFigure 2 Hypoxia induced EMT of HCC cells while reversion occurred
reoxygenation-treated SMMC-7721 cells were recorded by light microscope
and Vimentin expression was performed on both hypoxically and normoxi
cadherin and Vimentin in SMMC-7721 was determined under the condition
as endogenous reference and mRNA level of SMMC-7721 under normoxia
independent experiments. (D) Protein expression of E-cadherin, N-cadherin
reoxygenation was determined by immunoblotting. β-actin was used as en
7721 cells undergoing normoxia, hypoxia and reoxygenation was calculate
microscopic fields (×400) was recorded in each experiment. Data was show
images of each group were shown.returned to normoxic conditions, its epithelial morph-
ology was regained (Figure 2A and Additional file 2:
Figure S1). Immunohistological staining showed that E-
cadherin protein was lost in majority of HCC cells,
whereas expressions of N-cadherin and Vimentin were
extensively detected in these cells under hypoxia
(Figure 2B). Immunofluorescent staining also confirmed
the enhanced expression of N-cadherin and Vimentin in
HCC cells under hypoxia (Additional file 3: Figure S2).under reoxygenation. (A) Morphological changes of hypoxia and
(×200). (B) Immunohistochemical analysis of E-cadherin, N-cadherin
cally cultured SMMC-7721 (×200). (C) mRNA levels of E-cadherin, N-
s of normoxia, hypoxia and reoxygenation by qPCR. GAPDH was used
was used as control. Data were shown as mean ± SD of three
and Vimentin in SMMC-7721 cells undergoing normoxia, hypoxia and
dogenous control. (E) The numbers of invasive and migrating SMMC-
d with crystal violet staining. The average numbers of ten random
n as mean ± SD of three independent experiments. Representative
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levels of EMT markers. Expression of E-cadherin was
gradually suppressed when HCC cells were hypoxically
cultured. Consistently, expression of N-cadherin and
Vimentin were increased. Recovery to normoxia reversed
the changes in the mRNA levels of these EMT markers
(Figure 2C). Immunoblotting analysis was used to detect
the expression of E-cadherin, N-cadherin and Vimentin
on protein level, showing a consistent expression profile
of these markers (Figure 2D). These data indicate that in-
duction of EMT by hypoxia is reversible.
Cancer cells underlying EMT have been documented to
possess a high motility. Thus, we evaluated the effect of hyp-
oxia on HCC motility. Our data showed that ability of mi-
gration and invasion was significantly increased when HCC
cells were cultured in hypoxic condition, as compared with
HCC cells cultured in normoxic condition (Figure 2E).Figure 3 CoCl2-induced HIF-1α stabilization promotes SNAI1 expressi
level of E-cadherin, N-cadherin, Vimentin, HIF-1α and SNAI1 was determine
qPCR. GAPDH was used as endogenous control and mRNA level of untreat
SD of three independent experiments. (B) Protein expression of E-cadherin
without CoCl2 treatment (100 μM) was determined by immunoblotting. β-
and migrating SMMC-7721 cells with and without CoCl2 exposure (100 μM
ten random microscopic fields (×400) was recorded in each experiment. D
Representative images of each group were shown.Moreover, ability of migration and invasion was significantly
decreased when hypoxia-cultured HCC cells were returned
to normoxic condition. In addition, we also investigated the
influence of hypoxia on colony formation capacity and cell
cycle progression of HCC cells, finding G0/G1 cell cycle ar-
rest (Additional file 4: Figure S3) and decreased numbers of
colony under this condition (Additional file 5: Figure S4).
These data indicate that hypoxia can induce EMT and in-
crease capacity of migration and invasion in HCC cells
CoCl2-induced HIF-1α stabilization promotes SNAI1
expression, EMT and invasion capacity of HCC cells
We intended to reveal the molecular mechanisms by which
hypoxia induced HCC cells to undergo EMT. Thus, we
treated SMMC-7721 cells with CoCl2 (100 μM) to prevent
the degradation of HIF-1α and estimated the mRNA
expression of E-cadherin, N-cadherin and Vimentin inon, EMT and invasion capacity of HCC cells. (A) mRNA expression
d in SMMC-7721 cells with and without CoCl2 exposure (100 μM) by
ed SMMC-7721cells was used as control. Data were shown as mean ±
, N-cadherin, Vimentin, HIF-1α and SNAI1 in SMMC-7721 cells with or
actin was used as endogenous reference. (C) The numbers of invasive
) was calculated with crystal violet staining. The average numbers of
ata was shown as mean ± SD of three independent experiments.
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in mRNA and protein levels of these genes as those found in
hypoxia-treated SMMC-7721 cells (Figure 3A and B). After
removal of CoCl2, expression of these genes was returned
to the basic level. Interestingly, mRNA and protein levels
of SNAI1 was elevated in SMMC-7721 cells after treat-
ment with CoCl2 and was returned to the basic level after
removal of CoCl2 (Figure 3A and B).
CoCl2-induced HIF-1α stabilization also affected the bio-
logical behaviors of SMMC-7721 cells. Cells treated with
CoCl2 were shown to have an increased ability of migration
and invasion, as compared with controls. After removal of
CoCl2, the increased ability of migration and invasion was
returned to normal (Figure 3C). These data indicate that
HIF-1α stabilization is able to promote SNAI1-involved
EMT in HCC cells and facilitate their invasion.
HIF-1α silencing in HCC cells inhibits SNAI1-mediated EMT
and invasion under CoCl2 treatment
To confirm the role of HIF-1α in SNAI1 expression and
EMT induction, we knockdowned expression of HIF-1αFigure 4 HIF-1α silencing in HCC cells inhibits SNAI1-mediated EMT a
SNAI1, E-cadherin, N-cadherin and Vimentin were determined in CoCl2-trea
(10 MOI) by qRT-PCR. GAPDH was used as endogenous reference and mRN
shown as mean ± SD of three independent experiments. (B) Protein levels
cells infected with Ad-scrambled or Ad-shHIF1a was determined by immun
numbers of invasive and migrating CoCl2-treated SMMC-7721 cells infected
staining. The average numbers of ten random microscopic fields (×400) wa
three independent experiments. Representative images of each group werin HCC cells by adenoviral vector expression shRNA
against HIF-1α and study expression of EMT related
genes. Our result showed that expression of SNAI1, N-
cadherin and Vimentin was reduced in CoCl2-treated
HCC cells after infection with Ad-shHIF1α, whereas E-
cadherin was increased in CoCl2-treated HCC cells after
infection with Ad-shHIF1α (Figure 4A and B). Silencing
of HIF-1α could significantly reduce migration and inva-
sion of HCC cells (Figure 4C). This data indicated that
HIF-1α played a key role in hypoxia-induced EMT and
cell migration as well as invasion.
HIF-1α promotes transcription of SNAI1 under hypoxic
condition
To further elucidate the mechanism underlying HIF-1α
triggered SNAI1 upregulation, we screened the sequence
of SNAI1 promoter by bioinformatics analysis and found
two putative HIF-1α responsive elements (HREs) local-
ized in −651 and −541 of this region (Figure 5A). The
existence of HERs in SNAI1 promoter raised the possi-
bility that HIF-1α may regulated the transcription ofnd invasion under CoCl2 treatment. (A) mRNA levels of HIF-1α,
ted SMMC-7721 cells infected with Ad-scrambled or Ad-shHIF1α
A level of untreated SMMC-7721cells was used as standard. Data were
of E-cadherin, N-cadherin and Vimentin in CoCl2-treated SMMC-7721
oblotting. β-actin was used as endogenous reference. (C) The
with Ad-scrambled or Ad-shHIF1α was calculated with crystal violet
s recorded in each experiment. Data was shown as mean ± SD of
e shown.
Figure 5 HIF-1α promotes transcription of SNAI1 under hypoxia condition. (A) Schematic diagram of SNAI1 promoter-luciferase construct
was shown with the location of HRE. (HRE: hypoxia response element) (B) SMMC-7721 cells were transfected with pGL3-basic vector or a series of
pGL3 vectors containing truncated SNAI1 promoters or promoters with mutated HRE (P1, P2, P3, P4, M1, M2 and MM) along with renilla luciferase
expression vector. Luciferase assay was performed after 2 days. The firefly luciferase activity was normalized by renilla luciferase activity. Data were
shown as mean ± SD of three independent experiments. (C) A model was shown for effect of HIF-1.alpha; on SNAI1-mediated EMT in HCC.
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a series of reporter vectors (P1-P4) where luciferase ex-
pressions were driven by SNAI1 promoters of various
lengths (Figure 5A). Luciferase activity was quantified
after SNAI1 promoter-driven vectors were transfected
into CoCl2-pretreated HCC cells. Our results showed
that short form of SNAI1 promoters containing two
HRE or one HRE at −541 had a slightly reduced activity,
whereas the shortest form of SNAI1 promoter without
HRE sites almost lost its activity (Figure 5B).
To further confirm the regulatory role of −541 HRE in
SNAI1 transcription, we generated several reporter vec-
tors containing mutant HRE sites (M1, M2 and MM)
(Figure 5A). Our results showed that SNAI1 gene pro-
moter only containing mutant HRE site at −651 had
slight reduced activity, whereas SNAI1 gene promoter
only containing mutant HRE site at −541 had significant
reduced activity. SNAI1 gene promoter containing mu-
tant HRE sites at −651 and −541 had the lowest activity
(Figure 5B). These data indicate that HRE at −541 site
plays an important role in transcription of SNAI1 by
HIF-1α. Taken together, we conclude that HIF-1α pro-
motes the expression of SNAI1 through recognizing the
HRE in its upstream region.
Discussion
In this study, we found the increased expression of HIF-
1α in HCC samples obtained from surgical resection. Ec-
topic expression profile of HIF-1α is correlated with poorprognosis and enhanced HCC invasion and metastasis.
Further analysis showed that increased HIF-1α level was
associated with loss of E-cadherin and overexpression of
SNAI1, N-cadherin and Vimentin. Our data suggest that
hypoxia may induce EMT of cancer cells in HCC.
To test this hypothesis, we treated HCC cells under
hypoxic condition. We found that hypoxia could induce
EMT in HCC cells and enhance cell migration and inva-
sion. Furthermore, we found that induction of EMT by
hypoxia was reversible when cells were returned to
normoxic condition. In addition, we confirmed that hyp-
oxia led to G0/G1 arrest of HCC cells, which is coincident
with previous reports [37-41]. CoCl2-induced HIF-1α
stabilization also promoted EMT in HCC cells. And
shRNA-mediated HIF-1α suppression was able to prevent
EMT. All these data confirm that HIF-1α is an important
stimulatory factor of EMT process in HCC cells.
The downstream target genes regulated by HIF-1α are
involved in angiogenesis, hypoxic metabolism, cancer
cell survival and invasion [10,42-46]. HIF-1α is also doc-
umented to be an upstream regulatory factor of many
EMT modulators, such as SNAI1, twist, Zeb1, SIP1 and
LOX [47]. Recent studies revealed that HIF-1α-induced
LOX overexpression promoted the metastasis of breast
cancers in a mouse model and was correlated with poor
prognosis of ER negative patients [48]. Response to hyp-
oxia was also utilized in tumor therapy in the field of
gene therapy. Oncolytic adenoviruses were shown to se-
lectively and effectively proliferate in cancer cells, when
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promoters [49]. It is well demonstrated that SNAI1 is an
inducer of EMT and it plays an important role in induc-
tion of EMT in HCC cells [50,51]. Thus, we investigated
the potential effect of HIF-1α on SNAI1 expression.
Bioinformatics analysis on SNAI1 promoter identified
two putative HREs, providing the possibility that HIF-1α
can directly bind these sites and promoter SNAI1 tran-
scription. Using luciferase report systems, we deter-
mined that vectors containing either of these two HREs
had high luciferase activity in CoCl2-treated HCC cells.
The vector containing -651 bp HRE apparently had
higher luciferase expression than that harboring -541 bp
HRE. Previous study has shown that hypoxia could in-
duce Snail expression during EMT [52]. Recently, Luo
et al. demonstrated that HIF could directly regulated
mouse Snail expression [53]. Furthermore, it was reported
that hypoxia induced EMT in melanoma via regulation of
Snail by HIF-2α [54]. So we confirmed that HIF-1α pro-
moted the transcription of one of central EMT-inducer,
SNAI1, in hypoxia-simulating HCC model.
Collectively, we present our hypothesis of hypoxia
participating in EMT of HCC cells (Figure 5C). In hyp-
oxic conditions of the primary solid tumor, the oxygen
required for proline hydroxylase activity is absent. HIF-
1α in turn escapes proteolysis, allowing for its entry
into the nucleus. Then, it can dimerize with HIF-1β to
form the active transcription-stimulating complex,
which binds HRE in SNAI1 promoter to promote SNAI1
expression. The tumor cells acquire mesenchymal
phenotype, disseminate from the primary tumors, pene-
trate extracellular matrix (ECM) and enter blood or
lymphatic vessels. As soon as some of these tumors cells
penetrate ECM and enter the parenchyma of targeting
tissues or organs on the condition of reoxygenation,
HIF-1α is rapidly oxidized at either or both of two
proline residues by a proline hydroxylase enzyme. This
hydroxylation permits the binding of the von hippel-
landau protein (pVHL) to HIF-1α. Once bound, HIF-1α
is polyubiquitinated and subsequently degraded in the
proteasome. Subsequently, the mesenchymal tumor cells
undergo MET. HIF-1α may play a central role in EMT
induced by hypoxia. HIF-1α-SNAI1-EMT may be one of
the key signal pathways.
Conclusion
We found that in HCC, hypoxia-induced HIF-1α stabi-
lization promoted SNAI1-mediated EMT process, and led
to the enhanced HCC invasion and metastasis and poor
prognosis of patients. Further investigations to illuminate
the intimate mechanisms of hypoxia and reoxygenation in-
ducing solid tumors metastasis may lead to new molecular
therapies besides conventional treatments against malig-
nant solid tumors.Additional files
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